2010
DOI: 10.1016/j.phymed.2010.02.005
|View full text |Cite
|
Sign up to set email alerts
|

Double-blind, placebo-controlled, randomised study of single dose effects of ADAPT-232 on cognitive functions

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
46
0

Year Published

2011
2011
2020
2020

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 51 publications
(47 citation statements)
references
References 12 publications
1
46
0
Order By: Relevance
“…Resveratrol, a SIRT1 activator, limits plaque formation in Alzheimer mutant mice (Solberg et al 2014). A combination of adaptogens, Eleutherococcus senticocus, Schisandra chinensis, and Rhodiola rosea, raises HSP levels (Panossian et al 2009) and improves memory and cognitive performance (Aslanyan et al 2010). Curcumin activates HSF1 (Teiten et al 2009) and augments memory function (Zhang et al 2015a).…”
Section: Hsf1 Inducers and Cognitive Preservationmentioning
confidence: 99%
“…Resveratrol, a SIRT1 activator, limits plaque formation in Alzheimer mutant mice (Solberg et al 2014). A combination of adaptogens, Eleutherococcus senticocus, Schisandra chinensis, and Rhodiola rosea, raises HSP levels (Panossian et al 2009) and improves memory and cognitive performance (Aslanyan et al 2010). Curcumin activates HSF1 (Teiten et al 2009) and augments memory function (Zhang et al 2015a).…”
Section: Hsf1 Inducers and Cognitive Preservationmentioning
confidence: 99%
“…They possess adaptogenic and stress-protective (neuro-cardio and hepato protective) and antioxidant effects, as well as stimulating effects on the central nervous system, including on cognitive functions such as attention, memory and learning; anti-fatigue effects; antidepressive and anxiolytic effects; endocrine activity normalizing; and life-span increasing effects (Aslanyan et al, 2010; Sarris et al, 2011; Panossian et al, 2013). The main active compounds are reputedly phenylpropanoids (rosavin, rosarin, rosin) and phenylethanoids (salidroside and tyrosol).…”
Section: Introductionmentioning
confidence: 99%
“…Adverse events (AEs) due to R. rosea intake are rare and mild (sleepiness and cold extremities) (Aslanyan et al 2010;Hung et al 2011). R. rosea has the potential to enhance the action of stimulating medications, therefore, should not be used concomitantly with such medications.…”
Section: Clinical Trialsmentioning
confidence: 99%